These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20829534)

  • 1. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.
    Reischauer C; Froehlich JM; Koh DM; Graf N; Padevit C; John H; Binkert CA; Boesiger P; Gutzeit A
    Radiology; 2010 Nov; 257(2):523-31. PubMed ID: 20829534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study on the detection of antiandrogen resistance using serial diffusion-weighted imaging of bone metastases in prostate cancer.
    Reischauer C; Koh DM; Froehlich JM; Patzwahl R; Binkert CA; Gutzeit A
    J Magn Reson Imaging; 2016 Jun; 43(6):1407-16. PubMed ID: 26587694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer.
    Kim AY; Kim CK; Park SY; Park BK
    AJR Am J Roentgenol; 2014 Dec; 203(6):W645-50. PubMed ID: 25415730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture analysis of apparent diffusion coefficient maps for treatment response assessment in prostate cancer bone metastases-A pilot study.
    Reischauer C; Patzwahl R; Koh DM; Froehlich JM; Gutzeit A
    Eur J Radiol; 2018 Apr; 101():184-190. PubMed ID: 29571795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
    Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
    Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
    Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    Song I; Kim CK; Park BK; Park W
    AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
    Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
    Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in diffusion-weighted images for visualizing prostate cancer during antiandrogen therapy: preliminary results.
    Nemoto K; Tateishi T; Ishidate T
    Urol Int; 2010; 85(4):421-6. PubMed ID: 21051871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.
    Kim SY; Lee SS; Byun JH; Park SH; Kim JK; Park B; Kim N; Lee MG
    Radiology; 2010 Jun; 255(3):815-23. PubMed ID: 20501719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
    Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.
    Perez-Lopez R; Mateo J; Mossop H; Blackledge MD; Collins DJ; Rata M; Morgan VA; Macdonald A; Sandhu S; Lorente D; Rescigno P; Zafeiriou Z; Bianchini D; Porta N; Hall E; Leach MO; de Bono JS; Koh DM; Tunariu N
    Radiology; 2017 Apr; 283(1):168-177. PubMed ID: 27875103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary glands: echo-planar versus PROPELLER Diffusion-weighted MR imaging for assessment of ADCs.
    Juan CJ; Chang HC; Hsueh CJ; Liu HS; Huang YC; Chung HW; Chen CY; Kao HW; Huang GS
    Radiology; 2009 Oct; 253(1):144-52. PubMed ID: 19789257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver diffusion-weighted MR imaging: reproducibility comparison of ADC measurements obtained with multiple breath-hold, free-breathing, respiratory-triggered, and navigator-triggered techniques.
    Chen X; Qin L; Pan D; Huang Y; Yan L; Wang G; Liu Y; Liang C; Liu Z
    Radiology; 2014 Apr; 271(1):113-25. PubMed ID: 24475860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
    Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
    Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of diffusion-weighted-MRI in prostate cancer.
    Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
    J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness.
    Litjens GJ; Hambrock T; Hulsbergen-van de Kaa C; Barentsz JO; Huisman HJ
    Radiology; 2012 Oct; 265(1):260-6. PubMed ID: 22923722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.